Aligos Therapeutics Inc
NASDAQ:ALGS

Watchlist Manager
Aligos Therapeutics Inc Logo
Aligos Therapeutics Inc
NASDAQ:ALGS
Watchlist
Price: 18.5139 USD -5.44%
Market Cap: 114.1m USD
Have any thoughts about
Aligos Therapeutics Inc?
Write Note

Wall Street
Price Targets

ALGS Price Targets Summary
Aligos Therapeutics Inc

Wall Street analysts forecast ALGS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALGS is 105.4 USD with a low forecast of 60.6 USD and a high forecast of 183.75 USD.

Lowest
Price Target
60.6 USD
227% Upside
Average
Price Target
105.4 USD
469% Upside
Highest
Price Target
183.75 USD
892% Upside
Aligos Therapeutics Inc Competitors:
Price Targets
PYC
PYC Therapeutics Ltd
64% Upside
BNTX
BioNTech SE
19% Upside
MCRB
Seres Therapeutics Inc
562% Upside
2696
Shanghai Henlius Biotech Inc
13% Upside
STRO
Sutro Biopharma Inc
209% Upside
GLPG
Galapagos NV
49% Upside
OCX
OncoCyte Corp
43% Upside
KRYS
Krystal Biotech Inc
14% Upside

Revenue
Forecast

Revenue Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Aligos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALGS's stock price target?
Price Target
105.4 USD

According to Wall Street analysts, the average 1-year price target for ALGS is 105.4 USD with a low forecast of 60.6 USD and a high forecast of 183.75 USD.

Back to Top